Maze Therapeutics Inc

MAZE NASDAQ Santé & Biotech États-Unis
25.68 $
3.38 %

Maze Therapeutics Inc se concentre sur le développement de thérapies génétiques pour le traitement de maladies complexes.

Performance & Momentum

6 Months 40.45 %
1 Year 122.18 %
3 Years 55.74 %
5 Years 61.00 %

Similar stocks to Maze Therapeutics Inc

Anantys Community

Be the first to share your analysis on Maze Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases